Case History: Chantix™/Champix™ (Varenicline Tartrate), a Nicotinic Acetylcholine Receptor Partial Agonist as a Smoking Cessation Aid

被引:20
|
作者
Coe, Jotham W. [1 ]
Rollema, Hans [1 ]
O'Neill, Brian T. [1 ]
机构
[1] Pfizer Global Res & Dev, Groton Labs, Groton, CT 06340 USA
关键词
RANDOMIZED CONTROLLED-TRIAL; 10-SUBSTITUTED CYTISINE DERIVATIVES; SUSTAINED-RELEASE BUPROPION; DISCRIMINATIVE STIMULUS; DOSE PHARMACOKINETICS; CHOLINERGIC-RECEPTOR; HEALTHY SMOKERS; BETA-2; SUBUNIT; IN-VIVO; (-)-CYTISINE;
D O I
10.1016/S0065-7743(09)04404-2
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
[No abstract available]
引用
收藏
页码:71 / +
页数:32
相关论文
共 50 条
  • [1] Varenicline tartrate -: Aid to smoking cessation -: Nicotinic α4β2 partial agonist
    Sorbera, LA
    Castañer, J
    [J]. DRUGS OF THE FUTURE, 2006, 31 (02) : 117 - 122
  • [2] Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid
    Rollema, H.
    Chambers, L. K.
    Coe, J. W.
    Glowa, J.
    Hurst, R. S.
    Lebel, L. A.
    Lu, Y.
    Mansbach, R. S.
    Mather, R. J.
    Rovetti, C. C.
    Sands, S. B.
    Schaeffer, E.
    Schulz, D. W.
    Tingley, F. D., III
    Williams, K. E.
    [J]. NEUROPHARMACOLOGY, 2007, 52 (03) : 985 - 994
  • [3] The Smoking Cessation Aid Varenicline (Chantix, Champix): Drug Discovery Inspired by Natural Products
    Rollema, H.
    [J]. PLANTA MEDICA, 2013, 79 (10) : 810 - 810
  • [4] Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation
    Oncken, Cheryl
    Gonzales, David
    Nides, Mitchell
    Rennard, Stephen
    Watsky, Eric
    Billing, Clare B.
    Anziano, Richard
    Reeves, Karen
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (15) : 1571 - 1577
  • [5] Pharmacodynamic and pharmacokinetic profiles of the alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist varenicline, a smoking cessation aid
    Rollema, Hans
    Faessel, Helene M.
    [J]. JOURNAL OF PEDIATRIC BIOCHEMISTRY, 2010, 1 (02) : 175 - 184
  • [6] Varenicline:: An α4β2 nicotinic receptor partial agonist for smoking cessation
    Coe, JW
    Brooks, PR
    Vetelino, MG
    Wirtz, MC
    Arnold, EP
    Huang, JH
    Sands, SB
    Davis, TI
    Lebel, LA
    Fox, CB
    Shrikhande, A
    Heym, JH
    Schaeffer, E
    Rollema, H
    Lu, Y
    Mansbach, RS
    Chambers, LK
    Rovetti, CC
    Schulz, DW
    Tingley, FD
    O'Neill, BT
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (10) : 3474 - 3477
  • [7] Efficacy and safety of varenicline, an α4β2 acetylcholine nicotinic receptor partial agonist, for smoking cessation in Japanese smokers
    Nakamura, Masakazu
    Fujimoto, Yoko
    Maruyama, Nami
    Ishibashi, Taro
    Reeves, Karen
    [J]. CIRCULATION, 2006, 114 (18) : 856 - 856
  • [8] Smoking cessation efficacy and safety of varenicline, an α4β2 nicotinic receptor partial agonist
    Tonstad, Serena
    [J]. JOURNAL OF CARDIOVASCULAR NURSING, 2006, 21 (06) : 433 - 436
  • [9] Efficacy and safety of the novel selective nicotinic receptor partial agonist varenicline for smoking cessation
    Oncken, C
    Watsky, E
    Reeves, K
    Anziano, R
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 381A - 381A
  • [10] The efficacy and tolerability of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, for smoking cessation in Taiwanese and Korean smokers
    Kim, Dac-Hyun
    Tsai, Shih-Tzu
    Cho, Hong-Jun
    Chang, Wen-Dau
    Kim, Cheol-Hwan
    Cheng, Huey-Shinn
    Cho, BeLong
    Guo, Fei-Rarl
    Paek, Yu-Jin
    Hsueh, Kuang-Chieh
    Billing, Clare B., Jr.
    Williams, Kathryn E.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 122 : 82 - 82